7/24/2026
White House debates psychedelic health policy
Internal discussions focus on potential therapeutic uses and regulatory challenges.
Topic archive
2 stories
7/24/2026
Internal discussions focus on potential therapeutic uses and regulatory challenges.
7/24/2026
White House adviser Heidi Overton shapes ibogaine policy amid internal disputes.